EMA Makes "Steady Progress" On Revising Pharmacovigilance Guideline For Pediatric Drugs
Executive Summary
The European Medicines Agency is revising its guideline on pharmacovigilance requirements for pediatric drugs to show how drug development plans can benefit from the new pharmacovigilance environment in both scientific and regulatory terms.